Park C S, Chang S H, Lee H S, Kim S H, Chang J W, Hong C D
Department of Physiology, University of Ulsan College of Medicine, Seoul, Korea.
Am J Physiol. 1996 Jul;271(1 Pt 1):C242-7. doi: 10.1152/ajpcell.1996.271.1.C242.
This study sought to identify specific enzyme(s) involved in the biochemical cascade of inhibition of renin secretion through Ca(2+)-calmodulin mediation with the use of inhibitors of protein kinase and phosphatases. Inhibition of renin secretion mediated by Ca(2+)-calmodulin was induced by incubating rat renal cortical slices in K(+)-rich depolarizing medium, producing > 50% inhibition. This inhibition was completely blocked by the calmodulin antagonist calmidazolium. The inhibitor of protein kinase with broad specificity, K-252a, blocked the inhibition of renin secretion. Neither KN-62, a specific inhibitor of Ca(2+)-calmodulin-dependent protein kinase II (CaMK II), nor specific inhibitors of protein phosphatase 2B (PP2B), cyclosporin A and FK-506, blocked the inhibition. On the other hand, all four known inhibitors specific for myosin light chain kinase (MLCK), with different chemical structures and mechanisms of inhibition (ML-9, ML-7, KT-5926 and wortmannin), almost completely protected renin secretion against the inhibition by Ca2+. In particular, ML-9 reversively protected > 77% secretion against the inhibition both in K(+)-rich medium alone and in combination with the calcium ionophore A-23187 in a concentration-dependent manner. Together, these findings from our present study provide the first evidence, albeit indirect in nature, for the possibility that activation of Ca(2+)-calmodulin-dependent MLCK at the downstream of Ca2+ influx into juxtaglomerular (JG) cells leads to phosphorylation of 20-kDa regulatory myosin light chain (MLC20). Through interaction with actin, the phosphorylated MLC20 may play an important role in the inhibitory stimulus-secretion coupling of renin.
本研究旨在通过使用蛋白激酶和磷酸酶抑制剂,确定参与通过Ca(2+)-钙调蛋白介导抑制肾素分泌的生化级联反应的特定酶。通过将大鼠肾皮质切片在富含K(+)的去极化培养基中孵育诱导由Ca(2+)-钙调蛋白介导的肾素分泌抑制,产生>50%的抑制。这种抑制被钙调蛋白拮抗剂氯咪巴唑完全阻断。具有广泛特异性的蛋白激酶抑制剂K-252a阻断了肾素分泌的抑制。Ca(2+)-钙调蛋白依赖性蛋白激酶II(CaMK II)的特异性抑制剂KN-62以及蛋白磷酸酶2B(PP2B)的特异性抑制剂环孢素A和FK-506均未阻断该抑制。另一方面,四种已知的对肌球蛋白轻链激酶(MLCK)具有特异性的抑制剂,具有不同的化学结构和抑制机制(ML-9、ML-7、KT-5926和渥曼青霉素),几乎完全保护肾素分泌免受Ca2+的抑制。特别是,ML-9在单独的富含K(+)的培养基中以及与钙离子载体A-23187联合使用时,以浓度依赖性方式可逆地保护>77%的分泌免受抑制。总之,我们本研究的这些发现提供了首个证据,尽管本质上是间接的,表明Ca2+流入近球(JG)细胞下游的Ca(2+)-钙调蛋白依赖性MLCK的激活可能导致20-kDa调节性肌球蛋白轻链(MLC20)的磷酸化。通过与肌动蛋白相互作用,磷酸化的MLC20可能在肾素的抑制性刺激-分泌偶联中起重要作用。